Andrew Lo - May 2, 2025 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Andrew Lo
Stock symbol
BBIO
Transactions as of
May 2, 2025
Transactions value $
-$3,849,900
Form type
4
Date filed
5/6/2025, 04:42 PM
Previous filing
Jun 24, 2024
Next filing
Jun 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lo Andrew Director C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO /s/ Andrew Lo 2025-05-06 0001679076

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Sale -$3.85M -100K -48.64% $38.50 106K May 2, 2025 By Andrew W. Lo and Nancy N. Lo JTWROS F1
holding BBIO Common Stock 48.1K May 2, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sale price of the shares sold from $38.155 to $38.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.